Literature DB >> 6438340

Lateral phase separation of phospholipids as a basis for increased permeability of membranes towards fluorescein and other chemical species.

G M Humphries, J P Lovejoy.   

Abstract

Using mouse spleen cells, before and after treatment with glutaraldehyde or mild hyperthermia, we observe a strong correlation between permeability to fluorescein and susceptibility to staining with N epsilon-dansyl-L-lysine (irrespective of the cells' ability to exclude trypan blue). We observe the same correlation using liposomes prepared from phosphatidylcholine and varying amounts of cholesterol. We have recently introduced N epsilon-dansyl-L-lysine as a fluorescent membrane stain, or "probe," whose uptake, we propose, is selective for phospholipid domains in membranes (G.M.K. Humphries & J.P. Lovejoy Biophys. J. 42:307-310, 1983; G.M.K. Humphries & J.P. Lovejoy J. Membrane Biol. 77:115-122, 1984). The results presented here are consistent with the hypothesis that the presence or absence of phospholipid domains in membranes also modifies their permeability toward fluorescein, and suggests that permeability towards other chemical species may be similarly affected. On the basis of work using liposomes, we believe this to be the case for carboxyfluorescein and for glucose.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438340     DOI: 10.1007/bf01868443

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  19 in total

1.  Potent immunosuppression by oxidized cholesterol.

Authors:  G M Humphries; H M McConnell
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

2.  Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters.

Authors:  B Rotman; B W Papermaster
Journal:  Proc Natl Acad Sci U S A       Date:  1966-01       Impact factor: 11.205

3.  Liposome-cell interaction: transfer and intracellular release of a trapped fluorescent marker.

Authors:  J N Weinstein; S Yoshikami; P Henkart; R Blumenthal; W A Hagins
Journal:  Science       Date:  1977-02-04       Impact factor: 47.728

4.  Permeability properties of phospholipid membranes: effect of cholesterol and temperature.

Authors:  D Papahadjopoulos; S Nir; S Oki
Journal:  Biochim Biophys Acta       Date:  1972-06-20

5.  Lateral diffusion in binary mixtures of cholesterol and phosphatidylcholines.

Authors:  J L Rubenstein; B A Smith; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  Surface areas of lipid membranes.

Authors:  M A Schwartz; H M McConnell
Journal:  Biochemistry       Date:  1978-03-07       Impact factor: 3.162

7.  The rippled structure in bilayer membranes of phosphatidylcholine and binary mixtures of phosphatidylcholine and cholesterol.

Authors:  B R Copeland; H M McConnel
Journal:  Biochim Biophys Acta       Date:  1980-06-20

8.  Phase equilibria in binary mixtures of phosphatidylcholine and cholesterol.

Authors:  D J Recktenwald; H M McConnell
Journal:  Biochemistry       Date:  1981-07-21       Impact factor: 3.162

9.  Membrane structure and the tenuously maintained resistance to staining with N epsilon-dansyl-L-lysine shown by many cells.

Authors:  G M Humphries; J P Lovejoy
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

10.  Lateral diffusion in inhomogeneous membranes. Model membranes containing cholesterol.

Authors:  J C Owicki; H M McConnell
Journal:  Biophys J       Date:  1980-06       Impact factor: 4.033

View more
  2 in total

1.  Modulation of adriamycin transport by hyperthermia as measured by fluorescence-activated cell sorting.

Authors:  G C Rice; G M Hahn
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Interaction of the macrolide antibiotic azithromycin with lipid bilayers: effect on membrane organization, fluidity, and permeability.

Authors:  A Berquand; N Fa; Y F Dufrêne; M P Mingeot-Leclercq
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.